Outdoor air pollution and respiratory health.


Journal

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
ISSN: 1815-7920
Titre abrégé: Int J Tuberc Lung Dis
Pays: France
ID NLM: 9706389

Informations de publication

Date de publication:
01 01 2023
Historique:
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: ppublish

Résumé

The need to address the impact of air pollution on health is reinforced by recent scientific evidence and the 2021 WHO Air Quality Guidelines (AQG). Air pollution is an avoidable risk factor causing a high burden for society with elevated deaths, health disorders, disabilities and huge socio-economic costs, especially in low- and middle-income countries. We have evaluated recent evidence from international reports, systematic reviews and official websites of international agencies. Growing evidence shows a causal relationship between air pollution exposure and acute lower respiratory infections, chronic obstructive pulmonary disease, asthma and lung cancer. Exposure to air pollution in both the short- and long-term has a serious impact on respiratory health. Harmful effects occur even at very low pollutant concentration levels, and there are no detectable thresholds below which exposure may be considered safe. The adverse respiratory health effects of air pollutants, even at low levels, are confirmed by recent epidemiological studies. Scientific respiratory societies and patient associations, along with other stakeholders in the health sector, should increase their engagement and advocacy to raise awareness of clean air policies and the latest WHO AQG.

Identifiants

pubmed: 36853127
doi: 10.5588/ijtld.22.0249
doi:

Substances chimiques

Air Pollutants 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-12

Auteurs

S Maio (S)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

G Sarno (G)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

S Tagliaferro (S)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

F Pirona (F)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

I Stanisci (I)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

S Baldacci (S)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

G Viegi (G)

Pulmonary Environmental Epidemiology Unit, Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH